{"product_id":"ramsaygds-five-forces-analysis","title":"Ramsay Sante Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFrom Overview to Strategy Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eRamsay Santé faces moderate buyer power, fragmented suppliers, and high regulatory barriers that shape its competitive landscape—while private equity-backed rivals and digital health entrants raise the threat of rivalry and substitutes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScarcity of Specialized Medical Professionals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Europe-wide shortage of qualified doctors, nurses and technicians gives these professionals strong leverage over Ramsay Santé; OECD data showed a 13% deficit in medical staff in EU countries by 2024, and demand rose further into late 2025. \u003c\/p\u003e\n\u003cp\u003eRamsay Santé must offer pay premiums—estimated at 8–15% above market in 2025 for specialists—and invest in better work conditions and training to retain staff. \u003c\/p\u003e\n\u003cp\u003eThis heavy reliance on human capital makes supplier power high, since skilled personnel directly drive revenue and capacity. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of Pharmaceutical and MedTech Giants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe global market for high-end medtech and specialty pharmaceuticals is highly concentrated: the top 10 suppliers control about 60–70% of advanced imaging, implantable devices, and orphan drugs as of 2024, giving them strong pricing power.\u003c\/p\u003e\n\u003cp\u003eRamsay Santé depends on these firms for life-saving devices and branded drugs, limiting its ability to negotiate; supplier concentration raises procurement costs and supplier-driven contract terms.\u003c\/p\u003e\n\u003cp\u003eBecause these supplies are essential, 2023–24 price increases (example: 5–8% in device list prices, 6% for specialty drugs) feed directly into operating margins, squeezing EBITDA unless offset by reimbursement moves or efficiency gains.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy and Utility Cost Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOperating Ramsay Santé’s large hospital network needs huge energy for HVAC and medical devices; hospitals can use 5–15 MWh per bed annually, so energy is a major supplier lever. European wholesale gas and power prices spiked in 2025—EU day-ahead power averaged ~120 EUR\/MWh H1 2025—pushing providers to accept monopoly utility terms. Fixed energy costs, often 20–30% of facility OPEX, are hard to cut when long-term contracts face geopolitical risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Infrastructure and IT Service Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe shift to integrated care pathways and electronic health records makes Ramsay Santé highly dependent on specialized EHR and cybersecurity vendors; global healthcare EHR spending reached about $31.5bn in 2024, concentrating leverage with few suppliers.\u003c\/p\u003e\n\u003cp\u003eHigh switching costs—data migration risks, regulatory compliance, and staff retraining—push total replacement costs into the millions per hospital; one mid-size European hospital reports €3–7m migration estimates.\u003c\/p\u003e\n\u003cp\u003eAs a result, vendors hold strong bargaining power on renewals and upgrades, often dictating multi-year subscription terms and price escalations of 3–7% annually.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 EHR market: $31.5bn\u003c\/li\u003e\n\u003cli\u003eEstimated migration: €3–7m\/hospital\u003c\/li\u003e\n\u003cli\u003eTypical annual price hikes: 3–7%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Accreditation Bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSuppliers of certification and safety-auditing services hold strong leverage because EU and French health law make external approval mandatory for Ramsay Santé’s hospitals and clinics; noncompliance risks license withdrawal and fines—France fined hospitals €1.2bn cumulatively for safety breaches in 2023–24 across sectors.\u003c\/p\u003e\n\u003cp\u003eRamsay Santé must meet standards from entities like HAS (Haute Autorité de Santé) and ISO\/EN norms, driving recurring audit costs and capital investments; in 2024 Ramsay Santé reported €78m in compliance-related operating expenses.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMandatory approvals give auditors non-negotiable power\u003c\/li\u003e\n\u003cli\u003eHAS and EU rules define concrete, enforceable standards\u003c\/li\u003e\n\u003cli\u003eLicense loss or fines (sector fines €1.2bn in 2023–24) is material risk\u003c\/li\u003e\n\u003cli\u003eRamsay Santé spent ~€78m on compliance in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare supply squeeze: staff shortages, concentrated suppliers \u0026amp; rising costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSupplier power is high: skilled staff shortages (OECD 13% deficit by 2024) force 8–15% pay premia in 2025; top 10 medtech\/pharma control ~60–70% of advanced supplies (2024), pushing device\/drug price rises of 5–8% and 6% respectively; energy costs averaged ~120 EUR\/MWh H1 2025, and EHR market was $31.5bn in 2024 with €3–7m migration costs per hospital.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical staff deficit (EU)\u003c\/td\u003e\n\u003ctd\u003e13% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialist pay premia\u003c\/td\u003e\n\u003ctd\u003e8–15% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedtech\/pharma concentration\u003c\/td\u003e\n\u003ctd\u003e60–70% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice\/drug price rises\u003c\/td\u003e\n\u003ctd\u003e5–8% \/ 6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEU power price H1 2025\u003c\/td\u003e\n\u003ctd\u003e~120 EUR\/MWh\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEHR market\u003c\/td\u003e\n\u003ctd\u003e$31.5bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMigration cost\/hospital\u003c\/td\u003e\n\u003ctd\u003e€3–7m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Five Forces analysis for Ramsay Santé that uncovers key drivers of competition, buyer and supplier power, threats from substitutes and new entrants, and strategic barriers protecting incumbents, with industry-backed insights for investor decks and strategy plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eRamsay Santé Porter’s Five Forces in a concise one-sheet—rapidly spot competitive pressures and relieve decision paralysis for executives and investors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Public Payors and Social Security\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn Europe Ramsay Santé faces concentrated public payors—national social security systems and government health agencies—that set reimbursement rates and capture pricing power; in France public payors covered ~77% of health spending in 2022 (OECD). These fixed tariffs limit Ramsay’s ability to raise prices and pass rising input costs to patients, squeezing margins—France’s hospital tariff growth averaged ~1.5% annually 2018–23. As a result Ramsay must drive volume, efficiency, or private-pay services to protect EBITDA.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfluence of Private Health Insurance Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpprivate insurers and mutuals negotiate bulk rates for policyholders pushing margins down in france the top five covered of complementary health market giving them scale to demand price cuts. as consolidation continues humanis others grew share groups push lower tariffs or exclusive deals ramsay sant often accepts tighter terms retain insured patient volumes which make up about revenue some hospitals.\u003e\n\u003c\/pprivate\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient Choice and Consumer Awareness\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIncreased transparency on hospital quality and outcomes lets patients pick elective care providers; in France 72% of patients consult online ratings and 38% compare wait times before booking (2024 Santé Publique France data). Patients now weigh facility quality and reputation, pushing Ramsay Santé to boost patient experience—Ramsay reported €2.1bn revenue in 2024 with €120m allocated to patient-care and digital initiatives. This consumer shift raises churn risk unless Ramsay deepens brand loyalty and shortens waits via capacity and tech investments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCorporate Health Contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpcorporate health contracts give large employers strong bargaining power over ramsay sant in european corporate spending rose about to an estimated billion so these buyers can demand discounts service kpis and bundled care switch providers if costs or quality slip.\u003e\n\u003cpmanaging these high-volume b2b accounts means continuous value proof: negotiated price cuts often exceed for large contracts client retention hinges on net promoter scores and slas a single lost corporate account can cut thousands of annual admissions.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLarge buyers: institutional leverage, can shift entire workforce\u003c\/li\u003e\n\u003cli\u003ePrice sensitivity: typical contract discounts 5–10%\u003c\/li\u003e\n\u003cli\u003eService risk: retention tied to SLAs, NPS, clinical outcomes\u003c\/li\u003e\n\u003cli\u003eFinancial impact: losing one major client reduces admissions and revenues materially\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmanaging\u003e\u003c\/pcorporate\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health Literacy and Self-Referral\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDigital platforms let patients self-refer to specialists, raising individual bargaining power as they no longer depend on one local clinic; global telehealth visits hit 1.8 billion in 2024, up 25% vs 2023, shifting demand to mobile-first providers.\u003c\/p\u003e\n\u003cp\u003eRamsay Santé must invest in UX, online booking, and teleconsults to capture tech-savvy patients—digital patient acquisition costs average €60–€120 in Europe, so platform ROI must beat this.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSelf-referral growth: telehealth +25% (2024)\u003c\/li\u003e\n\u003cli\u003eTelehealth volume: 1.8B visits (2024)\u003c\/li\u003e\n\u003cli\u003eAcq. cost Europe: €60–€120 per patient\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyers squeeze margins: tariffs, insurers \u0026amp; telehealth force Ramsay to cut prices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuyers wield strong price\/volume power: public payors set tariffs (France ~77% public spending 2022; hospital tariff growth ~1.5% pa 2018–23), insurers concentrate (~60% top-five complementary market 2024), corporates push discounts\/KPIs (EU corporate health ~€48bn 2024), and digital self-referral\/telehealth (1.8bn visits 2024) raises patient choice—forcing Ramsay to cut prices, boost efficiency, and invest in digital.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic share (France)\u003c\/td\u003e\n\u003ctd\u003e~77% (2022 OECD)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTariff growth\u003c\/td\u003e\n\u003ctd\u003e~1.5% pa (2018–23)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-5 insurers\u003c\/td\u003e\n\u003ctd\u003e~60% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTelehealth visits\u003c\/td\u003e\n\u003ctd\u003e1.8bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eRamsay Sante Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Ramsay Santé Porter’s Five Forces analysis you’ll receive—fully formatted, professionally written, and ready for immediate download after purchase; no placeholders or samples.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747019960697,"sku":"ramsaygds-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/ramsaygds-five-forces-analysis.png?v=1772194354","url":"https:\/\/matrixbcg.com\/products\/ramsaygds-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}